GlassScriptPhysician profile
Isnardo E Tremor
NPI 1538167390
$1,108.61
in general payments reported to CMS, 2019-2025
25 companies · $21.18 in 2025
The $21.18 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $136 · 2021: $41.47 · 2022: $296 · 2023: $47.79 · 2024: $42.03 · 2025: $21.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $213.23 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $113.82 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $94.30 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $72.91 | 2019 | |
| Dexcom, INC. | $63.21 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $56.68 | 2020-2022 | |
| Astellas Pharma US INC | $50.56 | 2020-2023 | Myrbetriq |
| Novartis Pharmaceuticals Corporation | $44.50 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.10 | 2019 | |
| Scilex Pharmaceuticals INC. | $41.61 | 2019 | |
| Sunovion Pharmaceuticals INC. | $40.06 | 2021-2022 | |
| Vertiflex, INC. | $31.38 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $29.53 | 2022 | |
| Abbvie INC. | $28.58 | 2022-2023 | Vraylar |
| Glaxosmithkline, LLC. | $28.10 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $23.96 | 2022 | |
| Mylan Specialty L.P. | $22.45 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.60 | 2019 | |
| Lilly USA, LLC | $15.07 | 2022 | |
| Novo Nordisk INC | $14.79 | 2022 | |
| Sanofi Pasteur INC. | $13.53 | 2019 | |
| Allergan, INC. | $12.76 | 2019 | |
| Emergent Biosolutions INC. | $12.55 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.18 | 2022 | |
| Merck Sharp & Dohme LLC | $11.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isnardo Tremor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.